S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)

ABSTRACT: This randomized clinical trial studies prophylactic colony stimulating factor management in patients with breast, colorectal or non-small cell lung cancer receiving chemotherapy and with risk of developing febrile neutropenia. Patients receiving chemotherapy may develop febrile neutropenia. Febrile neutropenia is a condition that involves fever and a low number of neutrophils (a type of white blood cell) in the blood. Febrile neutropenia increases the risk of infection. Colony stimulating factors are medications sometimes given to patients receiving chemotherapy to prevent febrile neutropenia. Colony stimulating factors are given to patients based on guidelines. Some clinics have an automated system that helps doctors decide when to prescribe them when there is a high risk of developing febrile neutropenia. Gathering information about the use of an automated system to prescribe prophylactic colony stimulating factor may help doctors use colony stimulating factor when it is needed.

DISEASE(S): Stage Iia Breast Cancer,Carcinoma,Stage 0 Non-small Cell Lung Cancer,Stage Iv Breast Cancer,Febrile Neutropenia,Stage Iiia Breast Cancer,Stage Iia Colorectal Cancer,Breast Neoplasms,Stage Ib Breast Cancer,Stage Ib Non-small Cell Lung Carcinoma,Lung Neoplasms,Stage Iiic Breast Cancer,Stage I Colorectal Cancer,Stage Iva Colorectal Cancer,Stage Iiia Colorectal Cancer,Stage 0 Colorectal Cancer,Stage Iiia Non-small Cell Lung Cancer,Stage Iib Non-small Cell Lung Carcinoma,Colorectal Neoplasms,Carcinoma, Non-small-cell Lung,Neutropenia,Stage Iic Colorectal Cancer,Stage Iiib Non-small Cell Lung Cancer,Stage Ia Non-small Cell Lung Carcinoma,Stage Iiib Colorectal Cancer,Breast Carcinoma In Situ,Stage 0 Breast Cancer,Stage Iiib Breast Cancer,Stage Ia Breast Cancer,Stage Iv Non-small Cell Lung Cancer,Fever,Stage Iia Non-small Cell Lung Carcinoma,Stage Iib Colorectal Cancer,Stage Ivb Colorectal Cancer,Stage Iiic Colorectal Cancer,Stage Iib Breast Cancer,Hyperthermia

PROVIDER: 2211802 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR